0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Peripheral Blood Mononuclear Cells (PBMC) Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-38E6752
Home | Market Reports | Health| Health Conditions
Global Peripheral Blood Mononuclear Cells PBMC Market Insights Forecast to 2028
BUY CHAPTERS

Global Peripheral Blood Mononuclear Cells (PBMC) Market Research Report 2025

Code: QYRE-Auto-38E6752
Report
March 2025
Pages:64
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Peripheral Blood Mononuclear Cells (PBMC) Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Peripheral Blood Mononuclear Cells (PBMC) Market

Peripheral Blood Mononuclear Cells (PBMC) Market

The global market for Peripheral Blood Mononuclear Cells (PBMC) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Peripheral Blood Mononuclear Cells (PBMC), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peripheral Blood Mononuclear Cells (PBMC).
The Peripheral Blood Mononuclear Cells (PBMC) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peripheral Blood Mononuclear Cells (PBMC) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peripheral Blood Mononuclear Cells (PBMC) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Peripheral Blood Mononuclear Cells (PBMC) Market Report

Report Metric Details
Report Name Peripheral Blood Mononuclear Cells (PBMC) Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type
  • ≥ 50 Million Cells
  • Other
Segment by Application
  • ELISPOT
  • Proliferation Assays
  • Immunogenicity Assays
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Lonza, STEMCELL Technologies, Zen-Bio, ATCC, AllCells
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Peripheral Blood Mononuclear Cells (PBMC) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Peripheral Blood Mononuclear Cells (PBMC) Market report?

Ans: The main players in the Peripheral Blood Mononuclear Cells (PBMC) Market are Lonza, STEMCELL Technologies, Zen-Bio, ATCC, AllCells

What are the Application segmentation covered in the Peripheral Blood Mononuclear Cells (PBMC) Market report?

Ans: The Applications covered in the Peripheral Blood Mononuclear Cells (PBMC) Market report are ELISPOT, Proliferation Assays, Immunogenicity Assays, Other

What are the Type segmentation covered in the Peripheral Blood Mononuclear Cells (PBMC) Market report?

Ans: The Types covered in the Peripheral Blood Mononuclear Cells (PBMC) Market report are ≥ 50 Million Cells, Other

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peripheral Blood Mononuclear Cells (PBMC) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 ≥ 50 Million Cells
1.2.3 Other
1.3 Market by Application
1.3.1 Global Peripheral Blood Mononuclear Cells (PBMC) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 ELISPOT
1.3.3 Proliferation Assays
1.3.4 Immunogenicity Assays
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peripheral Blood Mononuclear Cells (PBMC) Market Perspective (2020-2031)
2.2 Global Peripheral Blood Mononuclear Cells (PBMC) Growth Trends by Region
2.2.1 Global Peripheral Blood Mononuclear Cells (PBMC) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Peripheral Blood Mononuclear Cells (PBMC) Historic Market Size by Region (2020-2025)
2.2.3 Peripheral Blood Mononuclear Cells (PBMC) Forecasted Market Size by Region (2026-2031)
2.3 Peripheral Blood Mononuclear Cells (PBMC) Market Dynamics
2.3.1 Peripheral Blood Mononuclear Cells (PBMC) Industry Trends
2.3.2 Peripheral Blood Mononuclear Cells (PBMC) Market Drivers
2.3.3 Peripheral Blood Mononuclear Cells (PBMC) Market Challenges
2.3.4 Peripheral Blood Mononuclear Cells (PBMC) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peripheral Blood Mononuclear Cells (PBMC) Players by Revenue
3.1.1 Global Top Peripheral Blood Mononuclear Cells (PBMC) Players by Revenue (2020-2025)
3.1.2 Global Peripheral Blood Mononuclear Cells (PBMC) Revenue Market Share by Players (2020-2025)
3.2 Global Peripheral Blood Mononuclear Cells (PBMC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Peripheral Blood Mononuclear Cells (PBMC) Revenue
3.4 Global Peripheral Blood Mononuclear Cells (PBMC) Market Concentration Ratio
3.4.1 Global Peripheral Blood Mononuclear Cells (PBMC) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peripheral Blood Mononuclear Cells (PBMC) Revenue in 2024
3.5 Global Key Players of Peripheral Blood Mononuclear Cells (PBMC) Head office and Area Served
3.6 Global Key Players of Peripheral Blood Mononuclear Cells (PBMC), Product and Application
3.7 Global Key Players of Peripheral Blood Mononuclear Cells (PBMC), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Peripheral Blood Mononuclear Cells (PBMC) Breakdown Data by Type
4.1 Global Peripheral Blood Mononuclear Cells (PBMC) Historic Market Size by Type (2020-2025)
4.2 Global Peripheral Blood Mononuclear Cells (PBMC) Forecasted Market Size by Type (2026-2031)
5 Peripheral Blood Mononuclear Cells (PBMC) Breakdown Data by Application
5.1 Global Peripheral Blood Mononuclear Cells (PBMC) Historic Market Size by Application (2020-2025)
5.2 Global Peripheral Blood Mononuclear Cells (PBMC) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Peripheral Blood Mononuclear Cells (PBMC) Market Size (2020-2031)
6.2 North America Peripheral Blood Mononuclear Cells (PBMC) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2020-2025)
6.4 North America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Peripheral Blood Mononuclear Cells (PBMC) Market Size (2020-2031)
7.2 Europe Peripheral Blood Mononuclear Cells (PBMC) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2020-2025)
7.4 Europe Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peripheral Blood Mononuclear Cells (PBMC) Market Size (2020-2031)
8.2 Asia-Pacific Peripheral Blood Mononuclear Cells (PBMC) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Peripheral Blood Mononuclear Cells (PBMC) Market Size by Region (2020-2025)
8.4 Asia-Pacific Peripheral Blood Mononuclear Cells (PBMC) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Peripheral Blood Mononuclear Cells (PBMC) Market Size (2020-2031)
9.2 Latin America Peripheral Blood Mononuclear Cells (PBMC) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2020-2025)
9.4 Latin America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peripheral Blood Mononuclear Cells (PBMC) Market Size (2020-2031)
10.2 Middle East & Africa Peripheral Blood Mononuclear Cells (PBMC) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2020-2025)
10.4 Middle East & Africa Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza Peripheral Blood Mononuclear Cells (PBMC) Introduction
11.1.4 Lonza Revenue in Peripheral Blood Mononuclear Cells (PBMC) Business (2020-2025)
11.1.5 Lonza Recent Development
11.2 STEMCELL Technologies
11.2.1 STEMCELL Technologies Company Details
11.2.2 STEMCELL Technologies Business Overview
11.2.3 STEMCELL Technologies Peripheral Blood Mononuclear Cells (PBMC) Introduction
11.2.4 STEMCELL Technologies Revenue in Peripheral Blood Mononuclear Cells (PBMC) Business (2020-2025)
11.2.5 STEMCELL Technologies Recent Development
11.3 Zen-Bio
11.3.1 Zen-Bio Company Details
11.3.2 Zen-Bio Business Overview
11.3.3 Zen-Bio Peripheral Blood Mononuclear Cells (PBMC) Introduction
11.3.4 Zen-Bio Revenue in Peripheral Blood Mononuclear Cells (PBMC) Business (2020-2025)
11.3.5 Zen-Bio Recent Development
11.4 ATCC
11.4.1 ATCC Company Details
11.4.2 ATCC Business Overview
11.4.3 ATCC Peripheral Blood Mononuclear Cells (PBMC) Introduction
11.4.4 ATCC Revenue in Peripheral Blood Mononuclear Cells (PBMC) Business (2020-2025)
11.4.5 ATCC Recent Development
11.5 AllCells
11.5.1 AllCells Company Details
11.5.2 AllCells Business Overview
11.5.3 AllCells Peripheral Blood Mononuclear Cells (PBMC) Introduction
11.5.4 AllCells Revenue in Peripheral Blood Mononuclear Cells (PBMC) Business (2020-2025)
11.5.5 AllCells Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Peripheral Blood Mononuclear Cells (PBMC) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of ≥ 50 Million Cells
 Table 3. Key Players of Other
 Table 4. Global Peripheral Blood Mononuclear Cells (PBMC) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Peripheral Blood Mononuclear Cells (PBMC) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Peripheral Blood Mononuclear Cells (PBMC) Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Peripheral Blood Mononuclear Cells (PBMC) Market Share by Region (2020-2025)
 Table 8. Global Peripheral Blood Mononuclear Cells (PBMC) Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Peripheral Blood Mononuclear Cells (PBMC) Market Share by Region (2026-2031)
 Table 10. Peripheral Blood Mononuclear Cells (PBMC) Market Trends
 Table 11. Peripheral Blood Mononuclear Cells (PBMC) Market Drivers
 Table 12. Peripheral Blood Mononuclear Cells (PBMC) Market Challenges
 Table 13. Peripheral Blood Mononuclear Cells (PBMC) Market Restraints
 Table 14. Global Peripheral Blood Mononuclear Cells (PBMC) Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Peripheral Blood Mononuclear Cells (PBMC) Market Share by Players (2020-2025)
 Table 16. Global Top Peripheral Blood Mononuclear Cells (PBMC) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Blood Mononuclear Cells (PBMC) as of 2024)
 Table 17. Ranking of Global Top Peripheral Blood Mononuclear Cells (PBMC) Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Peripheral Blood Mononuclear Cells (PBMC) Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Peripheral Blood Mononuclear Cells (PBMC), Headquarters and Area Served
 Table 20. Global Key Players of Peripheral Blood Mononuclear Cells (PBMC), Product and Application
 Table 21. Global Key Players of Peripheral Blood Mononuclear Cells (PBMC), Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Peripheral Blood Mononuclear Cells (PBMC) Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Peripheral Blood Mononuclear Cells (PBMC) Revenue Market Share by Type (2020-2025)
 Table 25. Global Peripheral Blood Mononuclear Cells (PBMC) Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Peripheral Blood Mononuclear Cells (PBMC) Revenue Market Share by Type (2026-2031)
 Table 27. Global Peripheral Blood Mononuclear Cells (PBMC) Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Peripheral Blood Mononuclear Cells (PBMC) Revenue Market Share by Application (2020-2025)
 Table 29. Global Peripheral Blood Mononuclear Cells (PBMC) Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Peripheral Blood Mononuclear Cells (PBMC) Revenue Market Share by Application (2026-2031)
 Table 31. North America Peripheral Blood Mononuclear Cells (PBMC) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Peripheral Blood Mononuclear Cells (PBMC) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Peripheral Blood Mononuclear Cells (PBMC) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Peripheral Blood Mononuclear Cells (PBMC) Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Peripheral Blood Mononuclear Cells (PBMC) Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Peripheral Blood Mononuclear Cells (PBMC) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Peripheral Blood Mononuclear Cells (PBMC) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Lonza Company Details
 Table 47. Lonza Business Overview
 Table 48. Lonza Peripheral Blood Mononuclear Cells (PBMC) Product
 Table 49. Lonza Revenue in Peripheral Blood Mononuclear Cells (PBMC) Business (2020-2025) & (US$ Million)
 Table 50. Lonza Recent Development
 Table 51. STEMCELL Technologies Company Details
 Table 52. STEMCELL Technologies Business Overview
 Table 53. STEMCELL Technologies Peripheral Blood Mononuclear Cells (PBMC) Product
 Table 54. STEMCELL Technologies Revenue in Peripheral Blood Mononuclear Cells (PBMC) Business (2020-2025) & (US$ Million)
 Table 55. STEMCELL Technologies Recent Development
 Table 56. Zen-Bio Company Details
 Table 57. Zen-Bio Business Overview
 Table 58. Zen-Bio Peripheral Blood Mononuclear Cells (PBMC) Product
 Table 59. Zen-Bio Revenue in Peripheral Blood Mononuclear Cells (PBMC) Business (2020-2025) & (US$ Million)
 Table 60. Zen-Bio Recent Development
 Table 61. ATCC Company Details
 Table 62. ATCC Business Overview
 Table 63. ATCC Peripheral Blood Mononuclear Cells (PBMC) Product
 Table 64. ATCC Revenue in Peripheral Blood Mononuclear Cells (PBMC) Business (2020-2025) & (US$ Million)
 Table 65. ATCC Recent Development
 Table 66. AllCells Company Details
 Table 67. AllCells Business Overview
 Table 68. AllCells Peripheral Blood Mononuclear Cells (PBMC) Product
 Table 69. AllCells Revenue in Peripheral Blood Mononuclear Cells (PBMC) Business (2020-2025) & (US$ Million)
 Table 70. AllCells Recent Development
 Table 71. Research Programs/Design for This Report
 Table 72. Key Data Information from Secondary Sources
 Table 73. Key Data Information from Primary Sources
 Table 74. Authors List of This Report


List of Figures
 Figure 1. Peripheral Blood Mononuclear Cells (PBMC) Picture
 Figure 2. Global Peripheral Blood Mononuclear Cells (PBMC) Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Peripheral Blood Mononuclear Cells (PBMC) Market Share by Type: 2024 VS 2031
 Figure 4. ≥ 50 Million Cells Features
 Figure 5. Other Features
 Figure 6. Global Peripheral Blood Mononuclear Cells (PBMC) Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Peripheral Blood Mononuclear Cells (PBMC) Market Share by Application: 2024 VS 2031
 Figure 8. ELISPOT Case Studies
 Figure 9. Proliferation Assays Case Studies
 Figure 10. Immunogenicity Assays Case Studies
 Figure 11. Other Case Studies
 Figure 12. Peripheral Blood Mononuclear Cells (PBMC) Report Years Considered
 Figure 13. Global Peripheral Blood Mononuclear Cells (PBMC) Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Peripheral Blood Mononuclear Cells (PBMC) Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Peripheral Blood Mononuclear Cells (PBMC) Market Share by Region: 2024 VS 2031
 Figure 16. Global Peripheral Blood Mononuclear Cells (PBMC) Market Share by Players in 2024
 Figure 17. Global Top Peripheral Blood Mononuclear Cells (PBMC) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Blood Mononuclear Cells (PBMC) as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Peripheral Blood Mononuclear Cells (PBMC) Revenue in 2024
 Figure 19. North America Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Peripheral Blood Mononuclear Cells (PBMC) Market Share by Country (2020-2031)
 Figure 21. United States Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Peripheral Blood Mononuclear Cells (PBMC) Market Share by Country (2020-2031)
 Figure 25. Germany Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Peripheral Blood Mononuclear Cells (PBMC) Market Share by Region (2020-2031)
 Figure 33. China Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Peripheral Blood Mononuclear Cells (PBMC) Market Share by Country (2020-2031)
 Figure 41. Mexico Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Peripheral Blood Mononuclear Cells (PBMC) Market Share by Country (2020-2031)
 Figure 45. Turkey Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Lonza Revenue Growth Rate in Peripheral Blood Mononuclear Cells (PBMC) Business (2020-2025)
 Figure 49. STEMCELL Technologies Revenue Growth Rate in Peripheral Blood Mononuclear Cells (PBMC) Business (2020-2025)
 Figure 50. Zen-Bio Revenue Growth Rate in Peripheral Blood Mononuclear Cells (PBMC) Business (2020-2025)
 Figure 51. ATCC Revenue Growth Rate in Peripheral Blood Mononuclear Cells (PBMC) Business (2020-2025)
 Figure 52. AllCells Revenue Growth Rate in Peripheral Blood Mononuclear Cells (PBMC) Business (2020-2025)
 Figure 53. Bottom-up and Top-down Approaches for This Report
 Figure 54. Data Triangulation
 Figure 55. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Insulin Glargine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages
Type: Report
Code: QYRE-Auto-2316
Fri Mar 21 00:00:00 UTC 2025

Add to Cart

Global Bilirubin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages
Type: Report
Code: QYRE-Auto-35U2436
Fri Mar 21 00:00:00 UTC 2025

Add to Cart

Global Intracardiac Echocardiography Catheter Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7J13314
Fri Mar 21 00:00:00 UTC 2025

Add to Cart

Global End Stage Renal Disease Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2F6212
Fri Mar 21 00:00:00 UTC 2025

Add to Cart